25-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1072 23 1200 97 1181 189 1151
ERLYTX 79 2 104 5 61 7 43
GI 185 3 157 13 158 25 152
GU 398 3 157 21 256 42 256
LEUK 137 2 104 10 122 19 116
LUNG 181 3 157 18 219 32 195
LYMPH 393 5 261 36 438 59 359
MELAN 235 0 0 0 0 0 0
MMYEL 116 2 104 8 97 13 79
MULT 23 0 0 0 0 1 6
OTHER 45 2 104 6 73 9 55
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2868 45 2348 214 2605 396 2412

25-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 130 3 157 19 231 34 207
ERLYTX 10 0 0 0 0 0 0
GU 1 0 0 1 12 1 6
LEUK 622 6 313 49 597 91 554
LUNG 336 6 313 34 414 60 365
OTHER 34 0 0 0 0 1 6
PEOLC 121 1 52 3 37 5 30
PREV 226 1 52 18 219 38 231
SXQOL 580 16 835 65 791 98 597
Total 2060 33 1722 189 2301 328 1996

25-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1072 23 1200 97 1181 189 1151
CCD 130 3 157 19 231 34 207
ERLYTX 89 2 104 5 61 7 43
GI 185 3 157 13 158 25 152
GU 399 3 157 22 268 43 262
LEUK 759 8 417 59 718 110 670
LUNG 517 9 470 52 633 92 560
LYMPH 393 5 261 36 438 59 359
MELAN 235 0 0 0 0 0 0
MMYEL 116 2 104 8 97 13 79
MULT 23 0 0 0 0 1 6
OTHER 79 2 104 6 73 10 61
PEOLC 121 1 52 3 37 5 30
PREV 228 1 52 18 219 38 231
SXQOL 582 16 835 65 791 98 597
Total 4928 78 4070 403 4905 724 4408

25-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 689 16 835 61 743 135 822
ERLYTX 45 1 52 3 37 4 24
GI 134 3 157 10 122 17 103
GU 328 2 104 13 158 32 195
LEUK 83 1 52 7 85 13 79
LUNG 114 3 157 13 158 22 134
LYMPH 255 4 209 26 317 40 244
MELAN 149 0 0 0 0 0 0
MMYEL 72 1 52 4 49 8 49
MULT 8 0 0 0 0 0 0
OTHER 45 2 104 6 73 9 55
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1926 33 1722 143 1742 280 1705

25-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 115 3 157 17 207 30 183
ERLYTX 10 0 0 0 0 0 0
GU 1 0 0 1 12 1 6
LEUK 263 3 157 19 231 35 213
LUNG 212 4 209 21 256 33 201
OTHER 34 0 0 0 0 1 6
PEOLC 85 0 0 2 24 4 24
PREV 226 1 52 18 219 38 231
SXQOL 396 13 678 47 572 73 444
Total 1342 24 1253 125 1521 215 1308

25-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 883 22 1148 77 937 171 1041
CCD 148 3 157 17 207 34 207
ERLYTX 55 1 52 3 37 4 24
GI 138 3 157 10 122 17 103
GU 353 2 104 16 195 38 231
LEUK 346 4 209 26 317 48 292
LUNG 334 8 417 37 450 61 371
LYMPH 255 4 209 26 317 40 244
MELAN 149 0 0 0 0 0 0
MMYEL 67 1 52 4 49 8 49
MULT 30 0 0 4 49 6 37
OTHER 239 2 104 10 122 23 140
PEOLC 88 0 0 1 12 4 24
PREV 228 1 52 18 219 38 231
SXQOL 398 13 678 47 572 73 444
Total 3711 64 3339 296 3605 565 3438

25-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 888 21 1096 90 1096 149 907
ERLYTX 75 2 104 5 61 7 43
GI 109 3 157 9 110 16 97
GU 245 3 157 17 207 31 189
LEUK 103 2 104 7 85 12 73
LUNG 145 1 52 16 195 27 164
LYMPH 319 5 261 27 329 47 286
MMYEL 102 2 104 7 85 10 61
MULT 23 0 0 0 0 1 6
Total 2009 39 2035 178 2168 300 1826

25-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1915 28 1461 145 1765 275 1674
AFFIL 141 2 104 11 134 28 170
CCOP/NCORP 1212 27 1409 112 1364 192 1169
Non-SWOG 1659 20 1044 134 1631 228 1388
Total 4927 77 4018 402 4894 723 4401

25-FEB-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 Y 28-JAN-26

25-FEB-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S1905 T-ALL/T-LBL, Rel/Ref, OBI-3424 1 N 15-FEB-26
LUNG S1933 NSCLC, Stg II-III, RT + Atezo 1 N 15-FEB-26
OTHER NRGBN011 Brain, Lomustine + Temo vs Temo 1 E 12-FEB-26
OTHER NRGBN011 Brain, Lomustine + Temo vs Temo 2 E 12-FEB-26
OTHER A071701 BRAIN, Met, Geno-guided trial 0 E 05-FEB-26
OTHER A071701 BRAIN, Met, Geno-guided trial 1 E 05-FEB-26

25-FEB-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 16
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 11
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 10
LUNG LUNGMAP NSCLC, Adv, Master 1 6
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 6
LUNG LUNGMAP NSCLC, Adv, Master 2 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 5
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 4
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 3 3
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 3